<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="years, gemcitabine, a cytidine analog in clinical use for the" exact="treatment" post="of many solid tumors, was also shown to have"/>
 <result pre="clinical trials [2,3,4,5] and are currently in use for the" exact="treatment" post="of virus-infected patients. Another class of nucleoside analog drugs"/>
 <result pre="a cytidine analog that has been clinically used for the" exact="treatment" post="of various cancers [11,12]. However, in recent years, the"/>
 <result pre="[13]. More recently, gemcitabine was shown to effectively suppress ZIKV" exact="infection" post="and replication in human retinal pigment epithelium (RPE) cells,"/>
 <result pre="for the replication of HCV in Huh-7 cells and the" exact="infection" post="of HIV in U373-MAGI-CXCR4CEM cells, with estimated EC50s of"/>
 <result pre="EVs, initially performed on Coxsackievirus B3 (CVB3), was found from" exact="screening" post="FDA-approved drugs in CVB3 replicon-harboring Vero cells by our"/>
 <result pre="of RNA viruses and has a therapeutic potential for the" exact="treatment" post="of various virus-associated diseases. Moreover, it is possible that"/>
 <result pre="with this possibility, there has been a report that the" exact="infection" post="of HSV-1, which is a representative DNA virus classified"/>
 <result pre="threats to public health and which urgently need an effective" exact="treatment" post="during their early stages of infection. In this regard,"/>
 <result pre="of infection. In this regard, repurposing of gemcitabine for the" exact="treatment" post="of patients infected with these deadly viruses is a"/>
 <result pre="with other antiviral agents. In this manner, an effective antiviral" exact="treatment" post="may be achieved by the synergistic action of two"/>
 <result pre="inactivation by gemcitabineChemistry2007138507851510.1002/chem.20070026017636467 13.DyallJ.ColemanC.M.HartB.J.VenkataramanT.HolbrookM.R.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.JahrlingP.B.LaidlawM.et al.Repurposing of clinically developed drugs for" exact="treatment" post="of middle east respiratory syndrome coronavirus infectionAntimicrob. Agents Chemother.2014584885489310.1128/AAC.03036-1424841273"/>
 <result pre="Agents Chemother.2014584885489310.1128/AAC.03036-1424841273 14.KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.de BrabanderJ.K.KainovD.E.VapalahtiO.Obatoclax, saliphenylhalamide and gemcitabine inhibit zika virus" exact="infection" post="in vitro and differentially affect cellular signaling, transcription and"/>
 <result pre="affect cellular signaling, transcription and metabolismAntivir. Res.201713911712810.1016/j.antiviral.2016.12.02228049006 15.ZhangZ.YangE.HuC.ChengH.ChenC.Y.HuangD.WangR.ZhaoY.RongL.VignuzziM.et al.Cell-based high-throughput" exact="screening" post="assay identifies 2′,2′-difluoro-2′-deoxycytidine gemcitabine as a potential antipoliovirus agentACS"/>
 <result pre="acid augments interferon-stimulated gene expression and inhibits hepatitis C virus" exact="infection" post="in vitro and in vivoHepatology2012551673168310.1002/hep.2556222213147 31.PanattoniA.D’AnnaF.TrioloE.Antiviral activity of tiazofurin"/>
 <result pre="pyrimidine biosynthesisJ. Virol.2011856548655610.1128/JVI.02510-1021507975 42.SmeeD.F.HurstB.L.DayC.W.D282, a non-nucleoside inhibitor of influenza virus" exact="infection" post="that interferes with de novo pyrimidine biosynthesisAntivir. Chem. Chemother.20122226327210.3851/IMP210522516927"/>
 <result pre="and stat1-independent pathways in the control of primary dengue virus" exact="infection" post="in miceJ. Immunol.20051753946395410.4049/jimmunol.175.6.394616148142 45.SchogginsJ.W.Interferon-stimulated genes: Roles in viral pathogenesisCurr."/>
 <result pre="(+)ssRNA Picornaviridae Viral proliferation Viral replication Early step of virus" exact="infection" post="Vero cells HeLa cells 0.4 μM 2 μM &amp;gt;50"/>
</results>
